Epidemiology of cardiovascular risk factors: Non-behavioural risk factors
Archives of Cardiovascular Diseases · 2024-12 · 117 (12) · 761-769
DOI: 10.1016/j.acvd.2024.08.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Cardiovascular Diseases, 2024-12. Verfasst von Valérie Olié und 15 weiteren Autor:innen. Beteiligte Einrichtung: Public Health France (Santé Publique France), 94415 Saint-Maurice cedex, France. Electronic address: valerie.olie@santepubliquefrance.fr. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Heart Disease Risk Factors. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Ministère des Solidarités et de la Santé.
Abstract (Originalsprache)
Cardiovascular disease is the leading cause of death worldwide, and the second leading cause in France. Among the modifiable cardiovascular risk factors, metabolic diseases (hypertension, low-density lipoprotein hypercholesterolaemia, diabetes and obesity) play a major role, contributing to the development and progression of atherosclerosis. This review summarizes the latest epidemiological data available at a national level. In 2015, the prevalence among adults aged 18-74years was 17.2% for obesity, 7.4% for diabetes, 30.6% for hypertension, 23.3% for low-density lipoprotein hypercholesterolaemia and 1.5% for stage 3-5 chronic kidney disease. Awareness of these diseases among affected individuals was very poor, ranging from 23% for diabetes to 45% for hypertension. While the prevalence of obesity and hypertension remained stable between 2006 and 2015, the prevalence of diabetes increased significantly. Prevention of these risk factors, particularly through nutrition, as well as awareness and management of them, must be intensified to reduce the burden of cardiovascular diseases in France. Whereas the prevalence of metabolic factors remains higher in men, particular attention should also be paid to risk factors specific to women, such as gynaecological diseases (endometriosis, polycystic ovary syndrome) and pregnancy disorders (hypertensive disorders in pregnancy, gestational diabetes), which contribute significantly to cardiovascular risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Public Health France (Santé Publique France), 94415 Saint-Maurice cedex, France. Electronic address: valerie.olie@santepubliquefrance.fr.
- Public Health France (Santé Publique France), 94415 Saint-Maurice cedex, France.
- Pitié-Salpêtrière Hospital, AP-HP, 75013 Paris, France.
- Hôtel-Dieu University Hospital (CHU), AP-HP, Paris-Cité University, 75004 Paris, France.
- Bichat Hospital, AP-HP, 75018 Paris, France.
- Rangueil University Hospital (CHU), 31400 Toulouse, France.
Förderung
- Ministère des Solidarités et de la Santé
Zitieren
APA
Olié, V., Gabet, A., Grave, C., Helft, G., Fosse-Edorh, S., Piffaretti, C., Lailler, G., Verdot, C., Deschamps, V., Vay-Demouy, J., Vidal-Petiot, E., Duly-Bouhanick, B., Tuppin, P., Ferrières, J., Halimi, J. M., & Blacher, J. (2024). Epidemiology of cardiovascular risk factors: Non-behavioural risk factors. Archives of Cardiovascular Diseases, 117(12), 761-769. https://doi.org/10.1016/j.acvd.2024.08.005
Vancouver
Olié V, Gabet A, Grave C, Helft G, Fosse-Edorh S, Piffaretti C, et al. Epidemiology of cardiovascular risk factors: Non-behavioural risk factors. Archives of Cardiovascular Diseases. 2024;117(12):761-769. doi:10.1016/j.acvd.2024.08.005
BibTeX
@article{Oli2024,
author = {Olié, Valérie and Gabet, Amélie and Grave, Clémence and Helft, Gérard and Fosse-Edorh, Sandrine and Piffaretti, Clara and Lailler, Grégory and Verdot, Charlotte and Deschamps, Valérie and Vay-Demouy, Juliette and Vidal-Petiot, Emmanuelle and Duly-Bouhanick, Beatrice and Tuppin, Philippe and Ferrières, Jean and Halimi, Jean-Michel and Blacher, Jacques},
title = {Epidemiology of cardiovascular risk factors: Non-behavioural risk factors},
journal = {Archives of Cardiovascular Diseases},
year = {2024},
volume = {117},
number = {12},
pages = {761--769},
doi = {10.1016/j.acvd.2024.08.005}
}
EUVIMED